Nightingale’s health data platform offers novel scientific opportunities for large-scale health initiatives. Comprehensive health results can be given to both scientists and participants to advance research and personal health.
Nightingale is analysing the biomarker profiles of 500,000 blood samples from the UK Biobank, the world's largest health database. The comprehensive metabolic biomarker profiles will be analysed in 30 months to facilitate global medical research a wealth of scientific applications.